Kicking off with the world of mining, Sirius Minerals (LON:SXX) confirmed that the judicial review period for all key planning approvals granted for the York Potash mine has now ended.
The company said it is not aware of any challenges to the planning approval granted by the National ParkAuthority.
Speaking of fertiliser, African Potash (LON:AFPO) has agreed a £750,000 bridge facility that will meet its short-term working capital needs.
Elsewhere, Obtala Resources (LON:OBT) welcomed a Mozambican government move, which it says will safeguard the country's long term timber industry.
Rambler Metals and Mining’s (LON:RMM CVE:RAB) metal production rebounded as it processed first ore from a new zone at its Ming mine in Newfoundland.
The miner produced 4,788 tonnes of concentrate in the three months to October, 33% higher than a year ago though 6% lower than the preceding quarter.
Meanwhile, Bushveld Minerals (AIM: BMN), received notification from Jeremy Friedlander, a non-executive director, that for personal financial reasons he disposed of 1.2mln shares a 3p. Friedlander now holds no shares in the company.
Sticking with finances, Gulf Keystone Petroleum (LON:GKP) has confirmed the receipt of a US$15mln gross payment from the Kurdistan authorities.
It said the payment satisfies the company’s invoice for the month of November, and following payment the company’s cash position will be US$54.6mln.
Elsewhere in the oil space, Polo Resources (LON: POL) has taken an 8.4% stake in a Malaysia listed oil firm, whose assets, it says, are set for a step-jump on completion of two recent acquisitions.
Polo has subscribed for US$5mln of shares in Hibiscus Petroleum Berhad settled at US$4.238 a share - a 4.08% discount to the Hibiscus closing price yesterday.
MX Oil (LON:MXO) told investors it has now been pre-qualified, together with its partner, for the third phase of Mexico’s licensing round for onshore concessions.
The growth company incubator Imperial Innovations (LON:IVO) said one of portfolio companies, Kesios Therapeutics, has raised £19mln in its latest funding round.
In energy news, Fuel cell specialist Ceres Power (LON:CWR) said the latest version of its steel cell technology will allow it to tap into more of the commercial and residential energy market.
The latest release of its V3 steel cell platform improves efficiency and power density, the firm told investors in an update.
Renewable Energy Generation (LON:WIND) has agreed the sale of its wind and solar business to a fund run by Blackrock.
The green power group flagged the sale in October and Blackrock will pay £64.5mln, in line with the price indicated then.
Forbidden Technologies (LON:FBT) has got something tangible out the UN Climate Change conference in Paris, with the sale of a licence for its cloud-based video editing platform Forscene.
In the pharma space, Summit Therapeutics’ (LON:SUMM NASDAQ:SMMT) research alliance with Oxford University has passed the first milestone in its search for a treatment for the muscle wasting disorder DMD.
The two organisations are collaborating to develop utrophin modulators that can treat patients with the fatal disease that attacks boys primarily.
In other news, Challenger acquisitions (LON:CHAL) had a prospectus approved by the financial conduct authority and expects its shares to be readmitted to the London Stock Exchange shortly.
Finally, Microsaic Systems (LON:MSYS) has seen a sales recovery in the second half of 2015, and it now expects unit sales substantially ahead of the first half figures.